Clinical Trial

A Study of Incidence, Treatment Patterns, and Outcomes in Transfusion-dependent Lower-risk Myelodysplastic Syndromes in Spain

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 11, 2026 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to understand the incidence of transfusion dependent lower-risk myelodysplastic syndromes (TD LR-MDS) and describing real-world first-line treatment patterns, healthcare resource utilization, and associated clinical outcomes in adult patients with TD LR-MDS in Spain
Trial Details
NCT Number NCT07465029
Lead Sponsor Bristol-Myers Squibb
Conditions Lower-risk Myelodysplastic Syndromes (TD LR-MDS)
Enrollment 1,300 participants
Start Date 2026-02-02
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-11